ProShares Ultra Health Care Rating → The 2024 Gold Rush: Unleashing Market Potential (From Priority Gold) (Ad) Free RXL Stock Alerts $102.34 -0.42 (-0.41%) (As of 05/20/2024 ET) Add Compare Share Share RatingsStock AnalysisChartHoldingsOwnershipRatingsStock AnalysisChartHoldingsOwnershipRatings ProShares Ultra Health Care Aggregate Rating and Price Target (2024)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.RXL Aggregate RatingModerate Buy2.67Holdings in RXL have an aggregate rating of Moderate Buy based on 631 analyst ratings issued in the past year covering 44 companies (68.5% of the portfolio).RXL Aggregate Price Target$109.987.47% UpsideHigh Prediction$132.08Average Prediction$109.98Low Prediction$87.25Holdings in RXL have an aggregate price target of $109.98 and a range of $87.25 to $132.08 covering 44 companies (68.5% of the portfolio).RXL Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy1 Buy rating(s)Moderate Buy31 Moderate Buy rating(s)Hold11 Hold rating(s)Reduce1 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by ProShares Ultra Health Care Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 44 RXL Holdings Export to ExcelWeightIn ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings8.36%LLYEli Lilly and Company$783.48+1.8%5 of 5 stars2.84$769.53 -1.8%19Analyst Revision6.38%UNHUnitedHealth Group$517.29-1.4%5 of 5 stars2.83$570.05 10.2%184.90%JNJJohnson & Johnson$151.32-2.1%5 of 5 stars2.46$175.86 16.2%134.45%MRKMerck & Co., Inc.$131.00-0.1%5 of 5 stars2.58$131.33 0.3%12Analyst Revision3.85%ABBVAbbVie$164.62-1.1%5 of 5 stars2.79$176.14 7.0%14Analyst Forecast3.08%TMOThermo Fisher Scientific$594.09-0.2%5 of 5 stars2.71$607.35 2.2%17Analyst RevisionPositive News2.42%ABTAbbott Laboratories$103.26-0.8%5 of 5 stars2.67$121.50 17.7%9Positive News2.31%DHRDanaher$267.28+0.6%5 of 5 stars2.64$267.31 0.0%14Insider Selling2.27%AMGNAmgen$314.54+0.7%5 of 5 stars2.52$305.65 -2.8%212.17%PFEPfizer$28.53-0.4%5 of 5 stars2.40$35.86 25.7%151.87%ISRGIntuitive Surgical$400.03+0.3%5 of 5 stars2.76$396.17 -1.0%171.69%ELVElevance Health$541.62-1.1%4 of 5 stars2.92$587.42 8.5%13Positive News1.50%SYKStryker$329.73-1.5%5 of 5 stars2.78$365.94 11.0%181.50%MDTMedtronic$84.55-1.6%5 of 5 stars2.40$94.91 12.3%10Upcoming Earnings1.50%VRTXVertex Pharmaceuticals$445.87+0.1%4 of 5 stars2.48$432.18 -3.1%25Analyst Upgrade1.45%BSXBoston Scientific$75.37+1.0%4 of 5 stars2.95$75.32 -0.1%211.38%REGNRegeneron Pharmaceuticals$987.27+0.5%4 of 5 stars2.76$989.36 0.2%21Insider Selling1.34%CIThe Cigna Group$333.37-1.6%5 of 5 stars2.92$366.14 9.8%131.21%BMYBristol-Myers Squibb$43.36-1.5%5 of 5 stars2.11$60.00 38.4%191.11%GILDGilead Sciences$67.90+0.3%5 of 5 stars2.35$83.69 23.3%171.06%ZTSZoetis$174.47+0.2%5 of 5 stars3.00$211.75 21.4%70.97%MCKMcKesson$564.07-0.1%5 of 5 stars2.87$571.47 1.3%150.94%CVSCVS Health$57.41-0.5%5 of 5 stars2.60$76.75 33.7%200.91%BDXBecton, Dickinson and Company$237.13+0.4%5 of 5 stars2.80$281.40 18.7%5Positive News0.86%HCAHCA Healthcare$325.15+0.7%5 of 5 stars2.75$317.00 -2.5%16Analyst UpgradeInsider Selling0.73%EWEdwards Lifesciences$89.80+0.7%4 of 5 stars2.58$93.88 4.5%190.67%DXCMDexCom$130.69-0.5%5 of 5 stars2.93$141.67 8.4%14Analyst UpgradePositive News0.61%IDXXIDEXX Laboratories$530.07-2.5%4 of 5 stars2.67$580.38 9.5%9Insider Selling0.60%AAgilent Technologies$154.72+0.3%4 of 5 stars2.59$141.29 -8.7%170.57%MRNAModerna$141.01+6.1%4 of 5 stars2.24$126.46 -10.3%17Insider Selling0.57%IQVIQVIA$230.09-0.5%5 of 5 stars2.80$257.57 11.9%150.57%HUMHumana$355.17-0.3%5 of 5 stars2.47$424.50 19.5%19Analyst Forecast0.56%CNCCentene$77.57-0.6%5 of 5 stars2.50$85.23 9.9%12Analyst Revision0.49%CORCencora$221.05-0.5%4 of 5 stars2.70$233.90 5.8%100.46%GEHCGE HealthCare Technologies$81.75-0.1%4 of 5 stars2.60$94.80 16.0%10Short Interest ↑0.45%BIIBBiogen$231.58+0.4%5 of 5 stars2.65$288.46 24.6%26Positive News0.44%MTDMettler-Toledo International$1,518.29-0.3%4 of 5 stars2.14$1,257.14 -17.2%7Insider Selling0.43%RMDResMed$218.85+0.1%5 of 5 stars2.70$202.80 -7.3%100.35%WSTWest Pharmaceutical Services$342.78-3.6%5 of 5 stars2.80$435.20 27.0%5Analyst Revision0.34%ZBHZimmer Biomet$119.15-0.9%5 of 5 stars2.29$133.29 11.9%14Dividend AnnouncementAnalyst Forecast0.31%CAHCardinal Health$98.46-0.6%5 of 5 stars2.50$107.57 9.3%12Analyst Upgrade0.31%STESTERIS$232.76+0.0%4 of 5 stars2.50$241.60 3.8%6Insider Selling0.29%WATWaters$354.02-0.5%3 of 5 stars1.90$305.78 -13.6%100.27%MOHMolina Healthcare$343.80-1.1%5 of 5 stars2.40$404.90 17.8%10 This page (NYSEARCA:RXL) was last updated on 5/21/2024 by MarketBeat.com Staff From Our PartnersBill Gates is all about this tiny $2 stockTimothy SykesExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersThe 2024 Gold Rush: Unleashing Market PotentialPriority GoldNext President (Not Trump. Not Biden.)The Freeport SocietyConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThe #1 Crypto for AIWeiss RatingsShocking $16T Elon Musk Crypto LeakCrypto 101 MediaDid You Get Your Free Bitcoin Yet?Crypto Swap Profits Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ProShares Ultra Health Care Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
